Business Wire

Reliance Foundation and The Estée Lauder Companies Charitable Foundation Launch Multi-Year Partnership That Aims to Empower One Million Girls and Young Women in India

14.10.2026 12:10:00 CEST | Business Wire | Press Release

Share

Reliance Foundation and The Estée Lauder Companies Charitable Foundation, the philanthropic arm of The Estée Lauder Companies, have announced the launch of a multi-year partnership that aims to empower one million girls and young women across India.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014635257/en/

Mr. Stéphane de La Faverie, President and Chief Executive Officer, The Estée Lauder Companies, and President, The Estée Lauder Companies Charitable Foundation, and Ms. Isha Ambani, Director, Reliance Foundation.

The program is designed for girls and young women from 14 to 20 years of age, across both rural and urban communities, with a focus on building life skills and confidence. It will begin in the Indian states of Maharashtra and Madhya Pradesh, with plans to expand to other parts of the country in the future. The initiative will help girls and young women strengthen their digital and financial literacy, and inform them about future pathways such as educational courses, trainings and livelihoods, so they can make informed choices about the next stage of their lives.

Speaking on the partnership, Ms. Isha Ambani, Director, Reliance Foundation, said, “I believe every girl should have the confidence to dream big, the courage to lead, and the opportunity to fulfill her aspirations. I am delighted that through this partnership, Reliance Foundation and The Estée Lauder Companies Charitable Foundation are uniting to equip one million girls and young women with the resilience they need to realize their full potential — igniting a powerful transformation that extends from the individual to her household and to the entire community."

Mr. Stéphane de La Faverie, President and Chief Executive Officer, The Estée Lauder Companies, and President, The Estée Lauder Companies Charitable Foundation, added: “We are proud to partner with Reliance Foundation to create more opportunities for girls and young women in India that will build the skills they need to participate and thrive in the modern workforce. The Estée Lauder Companies was founded by an extraordinary woman entrepreneur, and today, women represent more than 80% of our global workforce. We know the tremendous impact that women can have when they have the opportunity to learn, lead and build their own futures. We are excited to work together to help more women and girls realize their potential and shape what comes next.”

A Shared Commitment to Advancing Progress for Women and Girls

This program brings together two organizations with a shared commitment to advancing progress for women and girls. It comes at a time when India’s economic growth presents an unprecedented opportunity and when increasing women’s participation in the workforce will be a key lever for change.

Reliance Foundation believes in the transformational power of empowering women and girls. Since 2010, through various focused initiatives, Reliance Foundation has been enhancing education, sports and livelihood opportunities, enabling agency for women and girls overall.

This also builds on The Estée Lauder Companies’ long-standing philanthropic commitment to India. For more than 20 years, The Estée Lauder Companies and its Charitable Foundation have partnered with local NGOs in India, enabling women and girls to thrive and advance through health, education, and entrepreneurship.

The program, jointly developed by Reliance Foundation and The Estée Lauder Companies Charitable Foundation, will focus on:

  • Life skills: building confidence and self-esteem, strengthening decision-making and leadership, and developing skills to deal with everyday challenges.
  • Digital and financial literacy: building knowledge and confidence to use digital tools and financial services safely and effectively.
  • Choice and agency: helping girls build the confidence and skills to make informed decisions and navigate social and cultural influences affecting their safety, mobility, education and work opportunities.
  • Providing information on future pathways, including education, livelihoods, employment and entrepreneurship, so that girls have a better understanding of the options available to them.

The initiative is being designed together with the nonprofit Girl Effect, leveraging its expertise to support on the development of the curriculum and learning resources for girls. The two-year program will offer in-person and digital trainings and capacity-building, working together with various grassroots implementation partners.

Through this program, Reliance Foundation and The Estée Lauder Companies Charitable Foundation are building on their shared vision of accelerating progress, opportunity and empowerment for women and girls.

About Reliance Foundation

Reliance Foundation, the philanthropic arm of Reliance Industries Limited, aims to play a catalytic role in addressing India’s development challenges through innovative and sustainable solutions. Led by Smt. Nita M Ambani, Founder and Chairperson, Reliance Foundation is relentlessly working for the overall well-being and enhanced quality of life for all, focusing on rural transformation, education, health, sports for development, disaster management, women empowerment, urban renewal and arts, culture and heritage, and has touched the lives of over 100 million people across India, in over 98,000 villages and urban locations. More on www.reliancefoundation.org.

About The Estée Lauder Companies Charitable Foundation

The Estée Lauder Companies Charitable Foundation (ELCCF) is the global philanthropic arm of The Estée Lauder Companies, a leader in prestige beauty. Turning The Estée Lauder Companies’ and Mrs. Estée Lauder’s legacy into action, the ELCCF supports nonprofit organizations that enable women and girls to thrive and advance through the transformative power of health, education, and entrepreneurship. The Foundation invests in programs worldwide that strengthen career readiness, workforce participation, and leadership development for women and girls, and supports scientists and practitioners advancing breakthroughs in breast cancer and women’s health.

ELC-C

View source version on businesswire.com: https://www.businesswire.com/news/home/20261014635257/en/

Contacts

Media Relations:
Brendan Riley
briley@estee.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance14.10.2026 14:00:00 CEST | Press Release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, today announced their latest research on antibody drug conjugate (ADC) research released at World ADC San Diego 2026. Results highlighted the pre-clinical performance of a selection of linker technology from Debiopharm’s MultiLINK™ Linker Technology suite (MLINK Select, MLINK Duo and MLINK HiSol), revealing positive implications for the development of next generation ADCs and for the future of cancer patients that require more innovative therapies to overcome their disease. Despite remarkable progress in the ADC field, many cancers remain difficult to treat due to biological complexities that challenge current-generation therapies. Tumor heterogeneity can enable cancer cells with low or absent target expression to escape treatment, while acquired resistance to single-payload ADCs may emerge over time and compr

Responsible AI for Children: IEEE Delivers a Trusted Safety Formula to Help Protect Kids Online14.10.2026 14:00:00 CEST | Press Release

The IEEE Standards Association, the global, consensus-building standards development organization of IEEE – the world’s largest technical professional organization and public charity dedicated to advancing technology for the benefit of humanity – today advanced its Responsible AI for Children (RAIC) Certification Program with the first product certified for children’s online safety. As children increasingly engage with digital and AI-enabled technologies, parents, educators, developers, and regulators want tools they can trust. IEEE’s Responsible AI for Children (RAIC) certification directly addresses these needs by translating global technical standards into a practical assessment for age-appropriate design and child safety – helping organizations prioritize children’s values, rights and well-being in their digital products and services. “As AI becomes part of children’s everyday lives, our responsibility as technology leaders has never been greater,” said Mary Ellen Randall, 2026 IEE

Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 202614.10.2026 14:00:00 CEST | Press Release

Takeda (TSE:4502/NYSE:TAK) announced detailed results from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) and Recombinant Human Hyaluronidase], which, if approved, has the potential to become the first facilitated SCIG 20% therapy for patients with Primary Immunodeficiency Disease (PID) administered up to once-monthly (every 3 to 4 weeks). Data in participants aged 16 years and older are featured in two late-breaking posters at the 22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026) in Maastricht, the Netherlands. Previously shared topline results showed the clinical trial met its primary endpoint, demonstrating pharmacokinetic (PK) comparability between TAK-881 and HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Secondary analyses showed TAK-881 demonstrated infection outcomes and safety and tolerability profil

Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Board of Directors14.10.2026 13:55:00 CEST | Press Release

Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and real-world asset (“RWA”) tokenization, today announced the appointment of Jeffrey Tirman to its Board of Directors, effective as of October 12, 2026. Mr. Tirman was designated by NYIAX, Inc. (“NYIAX”) in connection with Datavault AI's recently completed acquisition of NYIAX, and he previously served on NYIAX's board of directors. As a Datavault AI Shareholder, Mr. Tirman brings both an ownership perspective and extensive management experience to the Board. Mr. Tirman has more than 35 years of international investment management experience, focused on corporate transformation, capital strategy and value creation. He has led complex cross-border transactions to strengthen balance sheets, reorganize operations and realign capital structures, both as a primary shareholder and on behalf of independent shareholders. His transa

EZO Reaches Financial Close on €150 Million Senior Debt Facility14.10.2026 13:21:00 CEST | Press Release

EZO has reached financial close on a €150 million investment-grade, non-recourse, senior debt facility. The funding will finance the design, installation, operation and maintenance of over 3,000 charge points, representing over 100,000 kWs of capacity, across the UK and Ireland under mostly long-term public sector “PPP-like” concessions with an attractive risk allocation between the public and private sector that will significantly advance EV infrastructure delivery, on time and to budget. These charge points are estimated to generate well in excess of £1 billion in electricity sales over the next 20 years, a portion of which will be shared with the public sector while, at the end of the concession, the chargers will revert back to the public sector. Headquartered in Ireland, EZO has expanded rapidly into the mainland UK, which by 2027 will become its primary EV charging market. The company is building the capital base, technology and operational capability required to deliver reliable

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye